STOCK TITAN
  1. Home
  2. Sec-filings
  3. LLY
  4. [Form 4] ELI LILLY & Co Insider Trading Activity

Eli Lilly (NYSE: LLY) director granted shares in pay award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ELI LILLY & Co (LLY) director Gabrielle Sulzberger reported an acquisition of 4.1908 shares of common stock on August 17, 2026, as a grant/award. According to the director deferral plan, the value was deferred as stock units in lieu of cash compensation and will be settled in shares after her separation from service, bringing her directly held equivalent share balance to 3003.9096 shares.

Positive

  • None.

Negative

  • None.
Insider Sulzberger Gabrielle
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 4.1908 $1,183.16 $5K
Holdings After Transaction: Common Stock — 3,003.9096 shares (Direct)
Footnotes (1)
  1. F1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Shares acquired 4.1908 shares Grant/award of common stock on 2026-08-17
Award valuation price $1183.16 per share Value used for the deferred stock unit award
Holdings after transaction 3003.9096 shares Direct holdings following the reported award
Lilly Directors' Deferral Plan financial
"shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan"
stock units financial
"deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan"
Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.
separation from service financial
"will be settled in shares of common stock following the reporting person's separation from service"

FAQ

What insider transaction did LLY director Gabrielle Sulzberger report?
Gabrielle Sulzberger reported an award of 4.1908 shares of Eli Lilly common stock on August 17, 2026. The award represents deferred compensation credited as stock units under the company’s directors’ deferral plan.

How many LLY shares does Gabrielle Sulzberger hold after this Form 4 transaction?
After the reported award, Gabrielle Sulzberger holds the equivalent of 3003.9096 shares of Eli Lilly common stock directly. This figure reflects her position following the August 17, 2026 grant reported on Form 4.

At what price was the LLY stock award to Gabrielle Sulzberger valued?
The 4.1908-share award to Gabrielle Sulzberger was valued at $1183.16 per share. This price is used to calculate the deferred stock units she receives instead of cash compensation under the directors’ deferral plan.

How is the LLY director’s stock award settled under the Lilly Directors' Deferral Plan?
Under the Lilly Directors' Deferral Plan, the reported shares are deferred as stock units rather than delivered immediately. They will be settled in shares of common stock after Gabrielle Sulzberger’s separation from service as a director.

Was Gabrielle Sulzberger’s LLY transaction under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as a plan transaction. The reported activity is a grant/award of deferred stock units tied to director compensation, not an open-market trade under a trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sulzberger Gabrielle
(Last)(First)(Middle)
LILLY CORPORATE CENTER
(Street)
INDIANAPOLIS INDIANA 46285
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/17/2026A4.1908(1)A$1,183.163,003.9096D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Remarks:
/s/ Jonathan Groff for Gabrielle Sulzberger, pursuant to authorization on file08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR